Biden Responds to Calls to Cancel $50k in Student Loan Debt: “No”

Click here to read full article 

TipRanks­The Bot­tom Is in for These 2 Stocks? Ana­lysts Say ‘Buy’Today, we’re look­ing at two small-cap biotech firms whose stocks have struck a rut. Each com­pa­ny has hit a recent clin­i­cal set­back that sent the share price falling, eras­ing pre­vi­ous gains and send­ing it back down to low lev­els. Set­backs of this sort are not uncom­mon in the biotech indus­try, and in fact high­light the risk and spec­u­la­tive nature of the indus­try. So what should investors do, when a stock col­laps­es? Is this a mat­ter of poor fun­da­men­tals? And has the stock’s price found its low point yet? …


Big Tech is at war with you! They don't want you to see the truth. Bookmark us and visit daily. 


Send this to a friend